In Vitro Selection of Short DNA Aptamers that Can Inhibit or Alleviate Cocaine and MK-801 Inhibition of Muscle-Type Nicotinic Acetylcholine Receptors-Reference-Cited by-同舟云学术

In Vitro Selection of Short DNA Aptamers that Can Inhibit or Alleviate Cocaine and MK-801 Inhibition of Muscle-Type Nicotinic Acetylcholine Receptors

Published:2021-09-21 Issue: Volume: Page:
ISSN:0022-2631
Container-title:The Journal of Membrane Biology
language:en
Short-container-title:J Membrane Biol

Author:

Sivaprakasam Kannan^ORCID,Hess George P.

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Physiology,Biophysics

Link

https://link.springer.com/content/pdf/10.1007/s00232-021-00202-0.pdf

Reference69 articles.

1. Aguayo LG, Albuquerque EX (1986) Effects of phencyclidine and its analogs on the end-plate current of the neuromuscular junction. J Pharmacol Exp Ther 239:15–24

2. Anderson P, Mecozzi S (2005) Identification of a 14mer RNA that recognizes and binds flavin mononucleotide with high affinity. Nucleic Acids Res 33:6992–6999. https://doi.org/10.1093/nar/gki992

3. Ansai T, Chen X, Barik S, Takehara T (2002) Conserved proline residues near the N-terminus are important for enzymatic activity of class A bacterial acid phosphatases. Arch Biochem Biophys 408:144–146. https://doi.org/10.1016/s0003-9861(02)00524-6

4. Aurup H, Williams DM, Eckstein F (1992) 2′-Fluoro- and 2′-amino-2′-deoxynucleoside 5′-triphosphates as substrates for T7 RNA polymerase. Biochemistry 31:9636–9641. https://doi.org/10.1021/bi00155a016

5. Baird SD, Hefford MA, Johnson DA et al (1990) The Glu residue in the conserved Asn-Glu-Pro sequence of two highly divergent endo-beta-1,4-glucanases is essential for enzymatic activity. Biochem Biophys Res Commun 169:1035–1039. https://doi.org/10.1016/0006-291x(90)91998-8

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor targeting and therapeutic assessments of RNA nanoparticles carrying α9-nAChR aptamer and anti-miR-21 in triple-negative breast cancers;Molecular Therapy - Nucleic Acids;2023-09